Fig. 2From: Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinomaBest overall response results of the three regimens (full-dose GC, dose-reduced GC, and GCa). Abbreviations: CR complete response, GC gemcitabine/cisplatin, GCa gemcitabine/carboplatin, PD progressive disease, PR partial response, SD stable diseaseBack to article page